Mark Lewis has been appointed CEO of Swift Biosciences, replacing Tim Harkins. Most recently, he held senior vice president roles in product development, general management, and customer support at Illumina. Previously, Lewis held R&D, commercial, and general management roles at various other companies, including BD Biosciences, Molecular Dynamics, Nycomed-Amersham, and Beckman Instruments.
Alan Copperman
Alan Copperman has joined health information firm Sema4 as its chief medical officer. Copperman serves as director of the division of reproductive endocrinology and infertility, and vice chairman of the department of obstetrics, gynecology, and reproductive science at the Icahn School of Medicine at Mount Sinai. He is also managing partner at Reproductive Medicine Associates of New York.
Paul Eros
Novacyt has appointed Paul Eros as commercial director, effective Nov. 1. Eros joins Novacyt from DiaSorin, where he was VP of molecular marketing for more than five years. He has also worked for Becton Dickinson and Roche Diagnostics.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.
